BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 28733053)

  • 1. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison.
    MD Anderson Head and Neck Cancer Symptom Working Group
    Radiother Oncol; 2017 Aug; 124(2):232-239. PubMed ID: 28733053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy.
    Caparrotti F; Huang SH; Lu L; Bratman SV; Ringash J; Bayley A; Cho J; Giuliani M; Kim J; Waldron J; Hansen A; Tong L; Xu W; O'Sullivan B; Wood R; Goldstein D; Hope A
    Cancer; 2017 Oct; 123(19):3691-3700. PubMed ID: 28608925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.
    Aarup-Kristensen S; Hansen CR; Forner L; Brink C; Eriksen JG; Johansen J
    Acta Oncol; 2019 Oct; 58(10):1373-1377. PubMed ID: 31364903
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.
    Owosho AA; Tsai CJ; Lee RS; Freymiller H; Kadempour A; Varthis S; Sax AZ; Rosen EB; Yom SK; Randazzo J; Drill E; Riedel E; Patel S; Lee NY; Huryn JM; Estilo CL
    Oral Oncol; 2017 Jan; 64():44-51. PubMed ID: 28024723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer.
    Tsai CJ; Hofstede TM; Sturgis EM; Garden AS; Lindberg ME; Wei Q; Tucker SL; Dong L
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):415-20. PubMed ID: 22795804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of mandibular dose distribution in radiotherapy for oropharyngeal cancer: dosimetric and clinical results in 18 patients.
    Jereczek-Fossa BA; Garibaldi C; Catalano G; d'Onofrio A; De Pas T; Bocci C; Ciocca M; DePaoli F; Orecchia R
    Radiother Oncol; 2003 Jan; 66(1):49-56. PubMed ID: 12559520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions.
    Ben-David MA; Diamante M; Radawski JD; Vineberg KA; Stroup C; Murdoch-Kinch CA; Zwetchkenbaum SR; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):396-402. PubMed ID: 17321069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients.
    Lee IJ; Koom WS; Lee CG; Kim YB; Yoo SW; Keum KC; Kim GE; Choi EC; Cha IH
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1084-91. PubMed ID: 19327914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.
    Zhang W; Zhang X; Yang P; Blanchard P; Garden AS; Gunn B; Fuller CD; Chambers M; Hutcheson KA; Ye R; Lai SY; Radwan MAS; Zhu XR; Frank SJ
    Radiother Oncol; 2017 Jun; 123(3):401-405. PubMed ID: 28549794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of osteoradionecrosis and dental events with dosimetric parameters in intensity-modulated radiation therapy for head-and-neck cancer.
    Gomez DR; Estilo CL; Wolden SL; Zelefsky MJ; Kraus DH; Wong RJ; Shaha AR; Shah JP; Mechalakos JG; Lee NY
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e207-13. PubMed ID: 21570202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk profile for osteoradionecrosis of the mandible in the IMRT era.
    Studer G; Bredell M; Studer S; Huber G; Glanzmann C
    Strahlenther Onkol; 2016 Jan; 192(1):32-9. PubMed ID: 26265308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity-modulated radiotherapy.
    Maesschalck T; Dulguerov N; Caparrotti F; Scolozzi P; Picardi C; Mach N; Koutsouvelis N; Dulguerov P
    Head Neck; 2016 Nov; 38(11):1695-1702. PubMed ID: 27240700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoradionecrosis of the mandible: minimized risk profile following intensity-modulated radiation therapy (IMRT).
    Studer G; Studer SP; Zwahlen RA; Huguenin P; Grätz KW; Lütolf UM; Glanzmann C
    Strahlenther Onkol; 2006 May; 182(5):283-8. PubMed ID: 16673062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis.
    Wong ATT; Lai SY; Gunn GB; Beadle BM; Fuller CD; Barrow MP; Hofstede TM; Chambers MS; Sturgis EM; Mohamed ASR; Lewin JS; Hutcheson KA
    Oral Oncol; 2017 Mar; 66():75-80. PubMed ID: 28249651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Dynamic Contrast-Enhanced MRI Identifies Radiation-Induced Vascular Damage in Patients With Advanced Osteoradionecrosis: Results of a Prospective Study.
    ; Mohamed ASR; He R; Ding Y; Wang J; Fahim J; Elgohari B; Elhalawani H; Kim AD; Ahmed H; Garcia JA; Johnson JM; Stafford RJ; Bankson JA; Chambers MS; Sandulache VC; Fuller CD; Lai SY
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1319-1328. PubMed ID: 32712257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers.
    Moon DH; Moon SH; Wang K; Weissler MC; Hackman TG; Zanation AM; Thorp BD; Patel SN; Zevallos JP; Marks LB; Chera BS
    Oral Oncol; 2017 Sep; 72():98-103. PubMed ID: 28797468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of osteoradionecrosis of the mandible.
    Boromand G; Haugen-Cange H; Asparusova M; Ekestubbe A; Kjeller G
    Acta Odontol Scand; 2024 Jan; 82(1):48-54. PubMed ID: 37772879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoradionecrosis rate in oropharynx cancer treated with dose volume histogram based constraints.
    Lee CT; Litwin S; Yao CMKL; Liu JC; Ridge JA; Galloway TJ
    Radiother Oncol; 2022 Nov; 176():215-221. PubMed ID: 36252636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predictive of severity of osteoradionecrosis of the mandible.
    Chopra S; Kamdar D; Ugur OE; Chen G; Peshek B; Marunick M; Kim H; Lin HS; Jacobs J
    Head Neck; 2011 Nov; 33(11):1600-5. PubMed ID: 21484922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic dosimetric evaluation of risk of osteoradionecrosis (DERO): First results of dose reporting for preventing teeth osteoradionecrosis after head and neck irradiation.
    Delpon G; Renouf M; Langé M; Blery P; Dupas C; Longis J; Thariat J; Doré M
    Cancer Radiother; 2023 Apr; 27(2):103-108. PubMed ID: 36739196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.